Orthopediatrics Corp
KIDSNasdaqCIK 1425450HealthcareFiscal year ends Dec 31
Reports and events: 213 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2716:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000092 |
| 2026-10-2716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000091 |
| 2026-09-1108:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-388676 |
| 2026-09-0118:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-378878 |
| 2026-08-0513:56 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001425450-26-000070 |
| 2026-08-0416:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000067 |
| 2026-08-0416:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000066 |
| 2026-06-0416:22 ET | 8-K | 5.07 Shareholder vote results | 0001425450-26-000041 |
| 2026-05-0115:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001425450-26-000036 |
| 2026-04-3016:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000033 |
| 2026-04-3016:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000032 |
| 2026-04-2016:57 ET | DEF 14A | Proxy statementPeriod 2026-04-20 | 0001425450-26-000027 |
| 2026-04-0117:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-038610 |
| 2026-03-0416:50 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001425450-26-000013 |
| 2026-02-2616:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000010 |
| 2026-02-2616:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000009 |
| 2026-01-1207:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000006 |
| 2026-01-1207:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000003 |
| 2025-10-2913:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001425450-25-000114 |
| 2025-10-2816:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000112 |
| 2025-10-2816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000111 |
| 2025-10-0916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000108 |
| 2025-08-1115:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001425450-25-000099 |
| 2025-08-0615:25 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001425450-25-000096 |
| 2025-08-0516:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000093 |
| 2025-08-0516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000092 |
| 2025-08-0516:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000090 |
| 2025-05-2712:19 ET | 8-K | 5.07 Shareholder vote results | 0001425450-25-000059 |
| 2025-05-1409:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001425450-25-000056 |
| 2025-05-0815:37 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001425450-25-000052 |
| 2025-05-0716:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000048 |
| 2025-05-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000047 |
| 2025-04-0210:06 ET | DEF 14A | Proxy statementPeriod 2025-04-02 | 0001425450-25-000033 |
| 2025-03-0610:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000017 |
| 2025-03-0514:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001425450-25-000015 |
| 2025-03-0416:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000012 |
| 2025-01-1408:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000009 |
| 2025-01-1316:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000005 |
| 2024-11-1210:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-24-000096 |
| 2024-11-0714:37 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001425450-24-000094 |
| 2024-11-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-24-000090 |
| 2024-10-1816:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001425450-24-000087 |
| 2024-09-1210:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-24-000085 |
| 2024-08-1216:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-088333 |
| 2024-08-0909:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-24-000081 |
| 2024-08-0614:39 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001425450-24-000079 |
| 2024-08-0517:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-24-000077 |
| 2024-08-0516:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-085842 |
| 2024-05-2811:34 ET | 8-K | 5.07 Shareholder vote results | 0001425450-24-000038 |
| 2024-05-2808:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-065338 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.